Cargando…

Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study

INTRODUCTION: Individualised treatment through therapeutic drug monitoring (TDM) may improve tuberculosis (TB) treatment outcomes but is not routinely implemented. Prospective clinical studies of drug exposure and minimum inhibitory concentrations (MICs) in multidrug-resistant TB (MDR-TB) are scarce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davies Forsman, Lina, Niward, Katarina, Hu, Yi, Zheng, Rongrong, Zheng, Xubin, Ke, Ran, Cai, Weiping, Hong, Chao, Li, Yang, Gao, Yazhou, Werngren, Jim, Paues, Jakob, Kuhlin, Johanna, Simonsson, Ulrika S H, Eliasson, Erik, Alffenaar, Jan-Willem, Mansjö, Mikael, Hoffner, Sven, Xu, Biao, Schön, Thomas, Bruchfeld, Judith
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Infectious Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173237/ https://www.ncbi.nlm.nih.gov/pubmed/30287613 http://dx.doi.org/10.1136/bmjopen-2018-023899

Ejemplares similares

Population pharmacokinetics and model-based dosing evaluation of bedaquiline in multidrug-resistant tuberculosis patients
por: Shao, Ge, et al.
Publicado: (2023)

Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosis
por: Zhang, Haoyue, et al.
Publicado: (2023)

Safety and pharmacokinetics-pharmacodynamics of a shorter tuberculosis treatment with high-dose pyrazinamide and rifampicin: a study protocol of a phase II clinical trial (HighShort-RP)
por: Ekqvist, David, et al.
Publicado: (2022)

Detection of Pyrazinamide Heteroresistance in Mycobacterium tuberculosis
por: Werngren, Jim, et al.
Publicado: (2021)

Correlation of drug exposure and bacterial susceptibility with treatment response for Mycobacterium avium complex lung disease: protocol for a prospective observational cohort study
por: Zheng, Xubin, et al.
Publicado: (2023)

Treatment of periprosthetic joint infections guided by minimum biofilm eradication concentration (MBEC) in addition to minimum inhibitory concentration (MIC): protocol for a prospective randomised clinical trial
por: Tillander, Jonatan A N, et al.
Publicado: (2022)

Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract
por: He, Guiqing, et al.
Publicado: (2022)

Drug exposure and susceptibility of second-line drugs correlate with treatment response in patients with multidrug-resistant tuberculosis: a multicentre prospective cohort study in China
por: Zheng, Xubin, et al.
Publicado: (2022)

Atypical Genetic Basis of Pyrazinamide Resistance in Monoresistant Mycobacterium tuberculosis
por: Modlin, Samuel J., et al.
Publicado: (2021)

Effect of the vancomycin minimum inhibitory concentration on clinical outcomes in patients with methicillin-susceptible Staphylococcus aureus bacteraemia: a systematic review and meta-analysis
por: Shi, Changcheng, et al.
Publicado: (2021)

Pyrazinamide-resistant Tuberculosis Obscured From Common Targeted Molecular Diagnostics
por: Modlin, Samuel J., et al.
Publicado: (2023)

Clinical impact of plasma concentrations of first-line antituberculosis drugs
por: Perumal, R, et al.
Publicado: (2023)

Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study
por: van den Elsen, Simone HJ, et al.
Publicado: (2020)

Study protocol for controlled human infection for penicillin G against Streptococcus pyogenes: a double-blinded, placebo-controlled, randomised trial to determine the minimum concentration required to prevent experimental pharyngitis (the CHIPS trial)
por: Hla, Thel Khin, et al.
Publicado: (2022)

A crowd of BashTheBug volunteers reproducibly and accurately measure the minimum inhibitory concentrations of 13 antitubercular drugs from photographs of 96-well broth microdilution plates
por: Fowler, Philip W, et al.
Publicado: (2022)

Incidence and predictors of acquired resistance to second-line antituberculosis drugs during the course of multi-drug resistant tuberculosis treatment: protocol for a systematic review and meta-analysis
por: Alemu, Ayinalem, et al.
Publicado: (2023)

The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of silver nanoparticles against Staphylococcus aureus
por: Parvekar, Prashik, et al.
Publicado: (2020)

Quantification of Natural Growth of Two Strains of Mycobacterium Marinum for Translational Antituberculosis Drug Development
por: Van Wijk, Rob C., et al.
Publicado: (2020)

Suboptimal Antituberculosis Drug Concentrations and Outcomes in Small and HIV‐Coinfected Children in India: Recommendations for Dose Modifications
por: Guiastrennec, Benjamin, et al.
Publicado: (2018)

First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia
por: Chabala, Chishala, et al.
Publicado: (2023)

Geographical concentration of falciparum malaria treated in the UK and delay to treatment with artesunate in severe cases: an observational study
por: Broderick, Claire, et al.
Publicado: (2012)

Serum concentrations of endothelial cell adhesion molecules and their shedding enzymes and early onset sepsis in newborns in Suriname
por: Zonneveld, Rens, et al.
Publicado: (2018)

THE MINIMUM CONCENTRATION OF OXYGEN FOR LUMINESCENCE BY LUMINOUS BACTERIA
por: Harvey, E. Newton, et al.
Publicado: (1923)

Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) for Twelve Antimicrobials (Biocides and Antibiotics) in Eight Strains of Listeria monocytogenes
por: Rodríguez-Melcón, Cristina, et al.
Publicado: (2021)

Augmented Renal Clearance and Hypoalbuminemia-Induced Low Vancomycin Trough Concentrations in Febrile Neutropenic Patients With Hematological Malignancies
por: Alzahrani, Abdullah M, et al.
Publicado: (2022)

The Relative Positioning of Genotyping and Phenotyping for Tuberculosis Resistance Screening in Two EU National Reference Laboratories in 2023
por: Anthony, Richard, et al.
Publicado: (2023)

Evidence for the utility of cfDNA plasma concentrations to predict disease severity in COVID-19: a retrospective pilot study
por: Hoeter, Katharina, et al.
Publicado: (2023)

Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case–control study
por: Doulgere, Julia, et al.
Publicado: (2015)

Minimum Intracanal Dressing Time of Triple Antibiotic Paste to Eliminate Enterococcus Faecalis (ATCC 29212) and Determination of Minimum Inhibitory Concentration and Minimum Bactericidal Concentration: An Ex Vivo Study
por: Ghabraei, Sholeh, et al.
Publicado: (2018)

Ethanol reduces the minimum alveolar concentration of sevoflurane in rats
por: Müller, Johannes, et al.
Publicado: (2022)

Bacterial antibiotic resistance development and mutagenesis following exposure to subminimal inhibitory concentrations of fluoroquinolones in vitro: a systematic literature review protocol
por: Ching, Carly, et al.
Publicado: (2019)

Reduced susceptibility of clinical strains of Mycobacterium tuberculosis to reactive nitrogen species promotes survival in activated macrophages
por: Idh, Jonna, et al.
Publicado: (2017)

Determination of minimum inhibitory and minimum bactericidal concentrations of Brazilian strains of Leptospira spp. for streptomycin sulphate
por: Rocha, Bruno Ribeiro, et al.
Publicado: (2020)

Misinterpretation of minimum alveolar concentration: Importance of entering demographic variables
por: Byrappa, Vinay, et al.
Publicado: (2014)

Minimum Alveolar Concentration of Sevoflurane with Cisatracurium for Endotracheal Intubation in Neonates
por: Zhang, Bin, et al.
Publicado: (2019)

The Minimum Inhibitory Concentration of Antibiotics: Methods, Interpretation, Clinical Relevance
por: Kowalska-Krochmal, Beata, et al.
Publicado: (2021)

Evaluation of clinicians’ knowledge and use of minimum inhibitory concentration values
por: Witt, Lucy S, et al.
Publicado: (2021)

Neurobiological basis and risk factors of persistent fatigue and concentration problems after COVID-19: study protocol for a prospective case–control study (VeCosCO)
por: Verveen, Anouk, et al.
Publicado: (2023)

Evaluation of crystal violet decolorization assay for minimal inhibitory concentration detection of primary antituberculosis drugs against Mycobacterium tuberculosis isolates
por: Coban, Ahmet Yilmaz, et al.
Publicado: (2016)

In vitro activity of new combinations of β-lactam and β-lactamase inhibitors against the Mycobacterium tuberculosis complex
por: Economou Lundeberg, Elin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t81ej7hchmjac5jmuak2udtd7a